Recombination Therapeutics
Biotechnology - , ,
Recombination Therapeutics Employees
Recombination Therapeutics Senior Management
Recombination Therapeutics Details
Recombination Therapeutics is a discovery stage DNA Damage Response (DDR) biotechnology company focused on developing best-in-class personalized cancer therapeutics. Recombination Therapeutics was established in 2018 with the goal of developing next-generation precision medicines for cancers with genetic defects in the DNA repair pathway called homologous recombination. Recombination's lead program is targeting DNA polymerase Theta (Polq) which is essential for the proliferation of recombination deficient cancer cells, but is dispensable for normal cells.
Website:
http://www.recombinationtx.com
Employees:
1
HQ:
Location:
, ,
Revenue:
Recombination Therapeutics Technologies
Email Providers
Outlook
Hosting
GoDaddy Hosting
Other
Mobile Friendly